Phosphorylation of the tumor suppressor p33ING1b at Ser-126 influences its protein stability and proliferation of melanoma cells

被引:42
|
作者
Garate, Marco
Campos, Eric I.
Bush, Jason A.
Xiao, Hao
Li, Gang
机构
[1] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Dept Dermatol & Skin Sci, Jack Bell Res Ctr, Vancouver, BC V6H 3Z6, Canada
[2] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA
[3] ImmuneChem Pharmaceut Inc, Burnaby, BC, Canada
来源
FASEB JOURNAL | 2007年 / 21卷 / 13期
关键词
protein half-life; cell proliferation;
D O I
10.1096/fj.07-8069com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ING (inhibitor of growth) tumor suppressors regulate cell-cycle checkpoints, apoptosis, and ultimately tumor suppression. Among the ING family members, p33(ING1b) is the most intensively studied and plays an important role in the cellular stress response to DNA damage. Here we demonstrate that there is basal phosphorylation of p33(ING1b) at Ser-126 in normal physiological conditions and that this phosphorylation is increased on DNA damage. The mutation of Ser-126 to alanine dramatically shortened the half-life of p33(ING1b). Furthermore, we found that both Chk1 and Cdk1 can phosphorylate this residue. Interestingly, while Cdk1 can phosphorylate p33(ING1b) at Ser-126 in nonstress conditions, Chk1 predominantly phosphorylates this residue on DNA damage, which suggests that p33(ING1b) is a downstream target of the ATM/ATR response cascade to genotoxic stress. More importantly, our data indicate that the Ser-126 residue plays a key role in regulating the expression of cyclin B1 and proliferation of melanoma cells.
引用
收藏
页码:3705 / 3716
页数:12
相关论文
共 46 条
  • [1] Mutation of the tumour suppressor p33ING1b is rare in melanoma
    Stark, M.
    Puig-Butille, J. A.
    Walker, G.
    Badenas, C.
    Malvehy, J.
    Hayward, N.
    Puig, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (01) : 94 - 99
  • [2] MAb 15B9 Against p33ING1b Tumor Suppressor Protein
    Atalay, Rengul
    HYBRIDOMA, 2009, 28 (01): : 77 - 77
  • [3] Generation of a polyclonal antibody specifically against the p33ING1b tumor suppressor
    Campos, EI
    Xiao, H
    Li, G
    JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, 2004, 25 (01): : 71 - 80
  • [4] The role of the tumour suppressor p33ING1b in human neoplasia
    Nouman, GS
    Anderson, JJ
    Lunec, J
    Angus, B
    JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (07) : 491 - 496
  • [5] Inhibitory effect of tumor suppressor p33ING1b and its synergy with p53 gene in hepatocellular carcinoma
    Mark A.Feitelson
    World Journal of Gastroenterology, 2005, (13) : 1903 - 1909
  • [6] Nuclear Exclusion of p33ING1b Tumor Suppressor Protein: Explored in HCC Cells Using a New Highly Specific Antibody
    Sayan, Berna
    Emre, Neset Cevdet Tolga
    Irmak, Meliha Burcu
    Ozturk, Mehmet
    Cetin-Atalay, Rengul
    HYBRIDOMA, 2009, 28 (01): : 1 - 6
  • [7] Inhibitory effect of tumor suppressor p33ING1b and its synergy with p53 gene in hepatocellular carcinoma
    Zhu, Zhi
    Lin, Jing
    Qu, Jian-Hui
    Feitelson, Mark A.
    Ni, Can-Rong
    Li, Fang-Mei
    Zhu, Ming-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (13) : 1903 - 1909
  • [8] The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells
    Zhu, JJ
    Li, FB
    Zhu, XF
    Liao, WM
    LIFE SCIENCES, 2006, 78 (13) : 1469 - 1477
  • [9] Genetic alterations and reduced expression of tumor suppressor p33ING1b in human exocrine pancreatic carcinoma
    Guan-Zhen Yu Ming-Hua Zhu Zhi Zhu Can-Rong Ni Jian-Ming Zheng Fang-Mei Li Department of Pathology
    World Journal of Gastroenterology, 2004, (24) : 3597 - 3601
  • [10] Genetic alterations and reduced expression of tumor suppressor p33ING1b in human exocrine pancreatic carcinoma
    Yu, Guan-Zhen
    Zhu, Ming-Hua
    Zhu, Zhi
    Ni, Can-Rong
    Zheng, Jian-Ming
    Li, Fang-Mei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (24) : 3597 - 3601